NZ742695A - Solid forms of substituted 5,6-dihydro-6-phenylbenzo[f]isoquinolin-2-amine compounds - Google Patents

Solid forms of substituted 5,6-dihydro-6-phenylbenzo[f]isoquinolin-2-amine compounds

Info

Publication number
NZ742695A
NZ742695A NZ742695A NZ74269516A NZ742695A NZ 742695 A NZ742695 A NZ 742695A NZ 742695 A NZ742695 A NZ 742695A NZ 74269516 A NZ74269516 A NZ 74269516A NZ 742695 A NZ742695 A NZ 742695A
Authority
NZ
New Zealand
Prior art keywords
approximately
polymorph
ray powder
powder diffraction
peaks
Prior art date
Application number
NZ742695A
Other languages
English (en)
Inventor
Craig Bates
David P Reed
Original Assignee
Arqule Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arqule Inc filed Critical Arqule Inc
Publication of NZ742695A publication Critical patent/NZ742695A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/78—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 2
    • C07D239/84—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NZ742695A 2015-12-17 2016-12-16 Solid forms of substituted 5,6-dihydro-6-phenylbenzo[f]isoquinolin-2-amine compounds NZ742695A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562268747P 2015-12-17 2015-12-17
PCT/US2016/067164 WO2017106642A1 (en) 2015-12-17 2016-12-16 Solid forms of substituted 5,6-dihydro-6-phenylbenzo[f]isoquinolin-2-amine compounds

Publications (1)

Publication Number Publication Date
NZ742695A true NZ742695A (en) 2022-10-28

Family

ID=59057612

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ742695A NZ742695A (en) 2015-12-17 2016-12-16 Solid forms of substituted 5,6-dihydro-6-phenylbenzo[f]isoquinolin-2-amine compounds

Country Status (19)

Country Link
US (3) US9981921B2 (enExample)
EP (2) EP3390369B1 (enExample)
JP (2) JP2018537499A (enExample)
KR (1) KR20180086508A (enExample)
CN (1) CN108368061A (enExample)
AU (2) AU2016369523B2 (enExample)
BR (1) BR112018012095A2 (enExample)
CA (1) CA3006081A1 (enExample)
EA (2) EA036295B1 (enExample)
ES (1) ES2935818T3 (enExample)
HK (1) HK1256825A1 (enExample)
IL (1) IL259556B2 (enExample)
MX (2) MX394320B (enExample)
NZ (1) NZ742695A (enExample)
PH (2) PH12018501246A1 (enExample)
SA (1) SA518391805B1 (enExample)
SG (1) SG11201804670PA (enExample)
TW (2) TWI771280B (enExample)
WO (1) WO2017106642A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017106639A1 (en) 2015-12-17 2017-06-22 Arqule, Inc. Methods for preparing substituted 5,6-dihydro-6-phenylbenzo[f]isoquinolin-2-amine
TWI771280B (zh) 2015-12-17 2022-07-21 美商亞闊股份有限公司 經取代之5,6-二氫-6-苯基苯并[f]異喹啉-2-胺化合物之固體形式
WO2022053708A1 (en) 2020-09-14 2022-03-17 Basilea Pharmaceutica International AG Pharmaceutical combinations for use in the treatment of gastric adenocarcinoma
JP7641247B2 (ja) 2022-03-02 2025-03-06 日立建機株式会社 機械の性能診断装置

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4522811A (en) 1982-07-08 1985-06-11 Syntex (U.S.A.) Inc. Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
WO1998028281A1 (en) 1996-12-23 1998-07-02 Celltech Therapeutics Limited Fused polycyclic 2-aminopyrimidine derivatives, their preparation and their use as protein tyrosine kinase inhibitors
GB9713087D0 (en) * 1997-06-20 1997-08-27 Celltech Therapeutics Ltd Chemical compounds
EP1638937B1 (en) * 2003-06-18 2008-12-17 Teva Pharmaceutical Industries Limited Fluvastatin sodium crystal form xiv, processes for preparing it, compositions containing it and methods of using it
EP2079736B1 (en) * 2006-12-29 2017-10-18 Rigel Pharmaceuticals, Inc. Substituted triazoles useful as axl inhibitors
MX2011006959A (es) * 2008-12-30 2011-12-06 Arqule Inc Compuestos substituidos de 5,6-dihidro-6-fenilbenzo [f] isoquinolina-2-amina.
KR20130105675A (ko) * 2010-11-25 2013-09-25 라티오팜 게엠베하 아파티닙의 신규 염 및 다형
WO2012177852A1 (en) * 2011-06-24 2012-12-27 Arqule, Inc Substituted imidazopyridinyl compounds
US9802954B2 (en) * 2011-08-24 2017-10-31 Boehringer Ingelheim International Gmbh Piperidino-dihydrothienopyrimidine sulfoxides and their use for treating COPD and asthma
EP2760859A1 (en) * 2011-09-30 2014-08-06 Sunshine Lake Pharma Co., Ltd Crystalline forms of azilsartan and preparation and uses thereof
TWI771280B (zh) * 2015-12-17 2022-07-21 美商亞闊股份有限公司 經取代之5,6-二氫-6-苯基苯并[f]異喹啉-2-胺化合物之固體形式
WO2017106639A1 (en) * 2015-12-17 2017-06-22 Arqule, Inc. Methods for preparing substituted 5,6-dihydro-6-phenylbenzo[f]isoquinolin-2-amine
US9847831B2 (en) 2016-04-08 2017-12-19 Ciena Corporation Dual wavelenth optical time domain reflectometer systems and methods embedded in a WDM system

Also Published As

Publication number Publication date
PH12018501246A1 (en) 2019-02-04
JP2018537499A (ja) 2018-12-20
EA202091691A1 (ru) 2021-01-29
US10227311B2 (en) 2019-03-12
AU2022201947B2 (en) 2023-07-27
SA518391805B1 (ar) 2022-12-21
WO2017106642A1 (en) 2017-06-22
MX394320B (es) 2025-03-24
TWI771280B (zh) 2022-07-21
HK1256825A1 (zh) 2019-10-04
EP3390369B1 (en) 2022-11-02
EP3390369A4 (en) 2019-08-14
US20200002293A1 (en) 2020-01-02
TWI796250B (zh) 2023-03-11
EA036295B1 (ru) 2020-10-22
US9981921B2 (en) 2018-05-29
PH12020551465A1 (en) 2021-07-26
TW202241854A (zh) 2022-11-01
KR20180086508A (ko) 2018-07-31
US20170174636A1 (en) 2017-06-22
AU2016369523B2 (en) 2021-12-23
EP4019499A1 (en) 2022-06-29
EA201891430A1 (ru) 2018-11-30
US10717710B2 (en) 2020-07-21
ES2935818T3 (es) 2023-03-10
CN108368061A (zh) 2018-08-03
JP2022031797A (ja) 2022-02-22
AU2016369523A1 (en) 2018-06-07
MX2018007414A (es) 2018-11-09
MX2021000432A (es) 2022-07-28
US20180258055A1 (en) 2018-09-13
BR112018012095A2 (pt) 2018-11-27
AU2022201947A1 (en) 2022-04-14
SG11201804670PA (en) 2018-07-30
CA3006081A1 (en) 2017-06-22
IL259556A (en) 2018-07-31
MX385671B (es) 2025-03-18
IL259556B1 (en) 2023-05-01
EP3390369A1 (en) 2018-10-24
IL259556B2 (en) 2023-09-01
TW201736352A (zh) 2017-10-16

Similar Documents

Publication Publication Date Title
UA129695C2 (uk) Спосіб отримання та кристалічні форми проміжного продукту в синтезі інгібітора mdm2
HRP20191979T1 (hr) Heteoarilni spojevi koji su korisni kao inhibitori sumo-aktivirajućeg enzima
NZ742695A (en) Solid forms of substituted 5,6-dihydro-6-phenylbenzo[f]isoquinolin-2-amine compounds
UA97478C2 (ru) Кристаллическая форма vi агомелатина, способ ее приготовления (варианты) и фармацевтическая композиция, которая ее содержит
RU2016151208A (ru) Радиоактивно меченные производные 2-амино-6-фтор-n-[5-фтор-пиридин-3-ил]-пиразоло[1, 5-а]пиримидин-3-карбоксамида, используемые в качестве ингибитора atr киназы, препараты на основе этого соединения и его различные твердые формы
MX354021B (es) Derivados de 5-fluor-4-imino-3- (sustituido) -3,4-dihidropirimidin -2 (1h) ona.
MY160785A (en) Manufacturing process for pyrimidine derivatives
HK1215579A1 (zh) 被取代的2，3-二氫苯並呋喃基化合物和其用途
RU2016146119A (ru) Новый кристалл тетрациклического соединения
PH12017501690A1 (en) Crystal of 3,5-disubstituted benzene alkynyl compound
MX381000B (es) Cristales de compuesto azabicíclico.
MY192027A (en) Novel abexinostate salt, associated crystalline form, preparation method thereof and the pharmaceutical compositions containing same
GEP20237490B (en) Polymorphs
TN2012000619A1 (fr) Forme cristalline delta du sel d'arginine du perindopril, son procede de preparation et les compositions pharmaceutiques qui la contiennent
JP2018537499A5 (enExample)
MY202100A (en) Crystal
WO2015178608A3 (ko) 3,4-디히드로퀴나졸린 유도체 및 그를 포함하는 복합제
WO2014155371A3 (en) Crystalline lenalidomide process
WO2017042837A3 (en) Stable crystalline form of regadenoson
RU2016145264A (ru) Соли и полиморфы замещенного имидазопиридинил-аминопиридина
NZ764730A (en) Polymorphs and solid forms of a pyrimidinylamino-pyrazole compound, and methods of production
NZ739083A (en) Plinabulin compositions
NZ757869A (en) Crystalline forms of (s)-afoxolaner
NZ739083B2 (en) Plinabulin compositions
NZ764150B2 (en) Radiolabelled derivatives of a 2-amino-6-fluoro-n-[5-fluoro-pyridin-3-yl]- pyrazolo[1,5-a]pyrimidin-3-carboxamide compound useful as ATR kinase inhibitor, the preparation of said compound and different solid forms thereof

Legal Events

Date Code Title Description
PSEA Patent sealed
LAPS Patent lapsed